Not admitted · Outcome already public
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 6 Oct 2024 · owen-1258
Quote
Outcome already public
“Gilead will allow for discount pricing for poor countries!”
Right after stating lenacapavir costs $42,250, the author says Gilead will allow discount pricing for poor countries. The tone is sarcastic, but the claim about Gilead's pricing policy reads as sincere.
The outcome had been publicly determined or announced by the deciding body or sponsor on the statement date.